Clinical Trials
4
Active:0
Completed:4
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Phase 4:2
Drug Approvals
2
NMPA:2
Drug Approvals
Compound Alverine Citrate Soft Capsules
- Product Name
- 乐健素
- Approval Number
- 国药准字HJ20140964
- Approval Date
- Aug 7, 2024
NMPA
Compound Alverine Citrate Soft Capsules
- Product Name
- 乐健素
- Approval Number
- H20140964
- Approval Date
- Nov 7, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (50.0%)Phase 2
1 (25.0%)Phase 3
1 (25.0%)Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing
Phase 3
Completed
- Conditions
- Colon Cleansing
- Interventions
- Drug: oral sodium phosphate tablets
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- Laboratoires Mayoly Spindler
- Target Recruit Count
- 461
- Registration Number
- NCT01840553
- Locations
- 🇫🇷
Hôpital Avicenne, Bobigny, France
🇫🇷Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France
🇫🇷Hopital Edouard Herriot, Lyon, France
Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)
Phase 4
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Drug: anti spasmodic agents
- First Posted Date
- 2011-07-28
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Laboratoires Mayoly Spindler
- Target Recruit Count
- 436
- Registration Number
- NCT01404923
Measurement of Gastric Emptying During and After COLOKIT® Intake
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- Laboratoires Mayoly Spindler
- Target Recruit Count
- 30
- Registration Number
- NCT01398098
- Locations
- 🇫🇷
Cochin Hospital, Paris, France
Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome
Phase 4
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Drug: placebo
- First Posted Date
- 2007-10-11
- Last Posted Date
- 2008-10-01
- Lead Sponsor
- Laboratoires Mayoly Spindler
- Target Recruit Count
- 400
- Registration Number
- NCT00542295
News
No news found